TFS
AUPH icon

TrustCore Financial Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

TrustCore Financial Services’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,590
Closed -$30K – 448
2018
Q3 		$30K Hold
4,590
– – 0.01% 372
2018
Q2 		$26K Buy
+4,590
New +$25.6K 0.01% 393

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TrustCore Financial Services's AUPH Position: Q4 2018 in Review

TrustCore Financial Services sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2018, closing a stake of 4,590 shares — an estimated $30K sold.

TrustCore Financial Services first reported a position in AUPH in Q2 2018 and held it in 2 quarters. The position peaked at $30K in Q3 2018. 61 funds tracked by Wall St. Rank hold AUPH as of Q4 2018.

  • TrustCore Financial Services reported no remaining Aurinia Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • TrustCore Financial Services sold 4,590 Aurinia Pharmaceuticals shares in Q4 2018, an estimated $30K.
  • TrustCore Financial Services first reported a position in Aurinia Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • TrustCore Financial Services's Aurinia Pharmaceuticals position peaked at $30K in Q3 2018.
  • 61 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2018.

Based on TrustCore Financial Services's 13F filing for Q4 2018, filed 5 Feb 2019.